Clinical Trial Update: Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating initial combination chemotherapy followed by donor bone marrow or umbilical cord blood transplantation in children with newly diagnos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Myelomonocytic Leukemia

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Juvenile Myelomonocytic Leukemia | Phase 2 | Status: COMPLETED